Sex steroids and malignancies (Q41517294)

2 October 2017

1 reference

title

Sex steroids and malignancies (English)

1 reference

2 October 2017

Baum M

1

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Osteoporosis International

2 October 2017

published in

1 reference

2 October 2017

volume

7 Suppl 1

1 reference

2 October 2017

page(s)

S18-22

1 reference

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer

2 October 2017

cites work

1 reference

12 December 2020

Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer

1 reference

12 December 2020

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

12 December 2020

Hormone replacement therapy in breast cancer survivors: a cohort study

1 reference

12 December 2020

Current and future roles of adjuvant endocrine therapy in the management of early carcinoma of the breast.

1 reference

12 December 2020

Hormones and breast cancer

1 reference

12 December 2020

In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen

1 reference

12 December 2020

Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration

1 reference

12 December 2020

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

12 December 2020

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1 reference

12 December 2020

Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications

1 reference

12 December 2020

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Carcinoma of the breast associated with pregnancy

1 reference

12 December 2020

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

12 December 2020

A report of 549 cases of breast cancer in women 35 years of age or younger

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01674808

1 reference

Dimensions Publication ID

2 October 2017

1014728314

0 references

1 reference